Nureca Past Earnings Performance
Past criteria checks 0/6
Nureca's earnings have been declining at an average annual rate of -38.2%, while the Medical Equipment industry saw earnings growing at 19.6% annually. Revenues have been declining at an average rate of 6.7% per year.
Key information
-38.2%
Earnings growth rate
-40.8%
EPS growth rate
| Medical Equipment Industry Growth | 23.0% |
| Revenue growth rate | -6.7% |
| Return on equity | -0.9% |
| Net Margin | -2.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope
Jul 12
Nureca Limited (NSE:NURECA) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Mar 29Nureca Limited's (NSE:NURECA) Shares Not Telling The Full Story
Jun 19Robust Earnings May Not Tell The Whole Story For Nureca (NSE:NURECA)
Jun 23Revenue & Expenses Breakdown
How Nureca makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 919 | -18 | 171 | 0 |
| 31 Dec 23 | 962 | 8 | 165 | 0 |
| 30 Sep 23 | 1,016 | 10 | 173 | 0 |
| 30 Jun 23 | 1,070 | -48 | 192 | 0 |
| 31 Mar 23 | 1,113 | -82 | 207 | 0 |
| 31 Dec 22 | 1,311 | -81 | 287 | 0 |
| 30 Sep 22 | 1,514 | -37 | 268 | 0 |
| 30 Jun 22 | 1,616 | 46 | 117 | 0 |
| 31 Mar 22 | 2,555 | 450 | 223 | 0 |
| 31 Dec 21 | 2,602 | 515 | 114 | 0 |
| 30 Sep 21 | 2,577 | 518 | 181 | 0 |
| 30 Jun 21 | 3,027 | 731 | 66 | 0 |
| 31 Mar 21 | 2,135 | 464 | 144 | 0 |
| 31 Mar 20 | 994 | 64 | 65 | 0 |
| 31 Mar 19 | 619 | 62 | 34 | 0 |
| 31 Mar 18 | 201 | 31 | 6 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
Quality Earnings: NURECA is currently unprofitable.
Growing Profit Margin: NURECA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NURECA is unprofitable, and losses have increased over the past 5 years at a rate of 38.2% per year.
Accelerating Growth: Unable to compare NURECA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NURECA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.9%).
Return on Equity
High ROE: NURECA has a negative Return on Equity (-0.93%), as it is currently unprofitable.